Sharps Technology, Inc. (STSS)
USD 4.75
(-9.35%)
USD 4.75
(-9.35%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -3.01 Million USD | 27.76% |
| 2022 | -4.17 Million USD | -435.31% |
| 2021 | -779.15 Thousand USD | 56.48% |
| 2020 | -1.79 Million USD | -181.7% |
| 2019 | -635.5 Thousand USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | -1.16 Million USD | 61.3% |
| 2024 Q2 | -1.48 Million USD | -27.22% |
| 2023 Q4 | -3.01 Million USD | 45.76% |
| 2023 Q2 | -2.92 Million USD | 44.38% |
| 2023 FY | -3.01 Million USD | 27.76% |
| 2023 Q1 | -5.25 Million USD | -26.05% |
| 2023 Q3 | -5.55 Million USD | -89.96% |
| 2022 Q3 | -6.38 Million USD | 18.16% |
| 2022 FY | -4.17 Million USD | -435.31% |
| 2022 Q2 | -7.8 Million USD | -1299.75% |
| 2022 Q1 | 650.81 Thousand USD | 183.53% |
| 2022 Q4 | -4.17 Million USD | 34.73% |
| 2021 Q1 | 1.79 Million USD | 200.0% |
| 2021 Q3 | -249.7 Thousand USD | 47.91% |
| 2021 Q4 | -779.15 Thousand USD | -212.03% |
| 2021 FY | -779.15 Thousand USD | 56.48% |
| 2021 Q2 | -479.35 Thousand USD | -126.78% |
| 2020 Q4 | -1.79 Million USD | 0.0% |
| 2020 FY | -1.79 Million USD | -181.7% |
| 2019 FY | -635.5 Thousand USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Akoya Biosciences, Inc. | 2.58 Million USD | 216.734% |
| AngioDynamics, Inc. | -70.14 Million USD | 95.705% |
| AtriCure, Inc. | -9.81 Million USD | 69.306% |
| Avinger, Inc. | 10.12 Million USD | 129.772% |
| Azenta, Inc. | -618.47 Million USD | 99.513% |
| BioLife Solutions, Inc. | 7.25 Million USD | 141.54% |
| The Cooper Companies, Inc. | 2.44 Billion USD | 100.123% |
| Daxor Corporation | 755.65 Thousand USD | 498.713% |
| Ekso Bionics Holdings, Inc. | -1.47 Million USD | -104.96% |
| Femasys Inc. | -15.01 Million USD | 79.934% |
| GlucoTrack, Inc. | -4.29 Million USD | 29.867% |
| Harvard Bioscience, Inc. | 38.49 Million USD | 107.828% |
| Hologic, Inc. | 374.4 Million USD | 100.805% |
| ICU Medical, Inc. | 1.45 Billion USD | 100.208% |
| Intuitive Surgical, Inc. | -2.66 Billion USD | 99.887% |
| KORU Medical Systems, Inc. | -7.03 Million USD | 57.185% |
| LeMaitre Vascular, Inc. | -5.17 Million USD | 41.768% |
| Innovative Eyewear, Inc. | -4.28 Million USD | 29.727% |
| Innovative Eyewear, Inc. | -4.28 Million USD | 29.727% |
| Masimo Corporation | 804 Million USD | 100.375% |
| Microbot Medical Inc. | -2.28 Million USD | -31.798% |
| Meihua International Medical Technologies Co., Ltd. | -9.59 Million USD | 68.602% |
| Merit Medical Systems, Inc. | 302.22 Million USD | 100.997% |
| Nephros, Inc. | -2.47 Million USD | -21.931% |
| NovoCure Limited | 355.42 Million USD | 100.848% |
| NEXGEL, Inc. | 98 Thousand USD | 3174.396% |
| NEXGEL, Inc. | 98 Thousand USD | 3174.396% |
| Singular Genomics Systems, Inc. | 59.05 Million USD | 105.102% |
| OraSure Technologies, Inc. | -276.9 Million USD | 98.912% |
| Pro-Dex, Inc. | 10.91 Million USD | 127.601% |
| Pulse Biosciences, Inc. | -35.22 Million USD | 91.446% |
| Predictive Oncology Inc. | -5.87 Million USD | 48.689% |
| Precision Optics Corporation, Inc. | 3.02 Million USD | 199.463% |
| QuidelOrtho Corporation | 2.49 Billion USD | 100.121% |
| Repligen Corporation | -39.51 Million USD | 92.376% |
| Sanara MedTech Inc. | 6.64 Million USD | 145.342% |
| STAAR Surgical Company | -147.2 Million USD | 97.953% |
| Utah Medical Products, Inc. | -92.52 Million USD | 96.744% |
| DENTSPLY SIRONA Inc. | 1.96 Billion USD | 100.153% |
| Jin Medical International Ltd. | -2.81 Million USD | -6.973% |